Person who experienced the adverse event (patient)
| Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122415456 | 12241545 | 6 | F | 201601 | 20160620 | 20160406 | 20160705 | EXP | GB-SUN PHARMACEUTICAL INDUSTRIES LTD-2016RR-114227 | RANBAXY | 22.18 | YR | F | Y | 64.10000 | KG | 20160705 | OT | GB | GB |
Drug(s) used by person
| Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 122415456 | 12241545 | 1 | PS | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 1 DF, 1 EVERY 72 HOURS FOR 3 DOSES THEN 1 WEEKLY | Y | U | 2677852 | 0 | 1 | DF | CAPSULE | ||||
| 122415456 | 12241545 | 2 | SS | FLUCONAZOLE. | FLUCONAZOLE | 1 | Oral | 150 MG, 2/WEEK (TOTAL AMOUNT WAS 450 MG) | Y | U | 0 | 150 | MG | CAPSULE | BIW | ||||
| 122415456 | 12241545 | 3 | C | LAMOTRIGINE. | LAMOTRIGINE | 1 | Oral | 100 MG, BID | U | U | 0 | 100 | MG | Q12H | |||||
| 122415456 | 12241545 | 4 | C | Flucloxacillin | FLUCLOXACILLIN | 1 | Oral | 1 G, QID | 20 | G | U | U | 0 | 1 | G | Q6H | |||
| 122415456 | 12241545 | 5 | C | LIDOCAINE. | LIDOCAINE | 1 | Unknown | U | U | 0 | |||||||||
| 122415456 | 12241545 | 6 | C | Gino-Daktarin | 2 | Unknown | U | U | 0 | ||||||||||
| 122415456 | 12241545 | 7 | C | CLOTRIMAZOLE. | CLOTRIMAZOLE | 1 | Topical | UNK | U | U | 0 | CREAM |
Indications of drugs used
| Event ID | CASEID | INDI DRUG SEQ | INDI PT |
|---|---|---|---|
| 122415456 | 12241545 | 1 | Vulvovaginal candidiasis |
| 122415456 | 12241545 | 3 | Epilepsy |
| 122415456 | 12241545 | 4 | Bacterial infection |
| 122415456 | 12241545 | 5 | Vulvovaginal candidiasis |
| 122415456 | 12241545 | 6 | Vulvovaginal candidiasis |
| 122415456 | 12241545 | 7 | Vulvovaginal candidiasis |
Outcome of event
| Event ID | CASEID | OUTC COD |
|---|---|---|
| 122415456 | 12241545 | OT |
Reactions reported
| Event ID | CASEID | DRUG REC ACT | PT |
|---|---|---|---|
| 122415456 | 12241545 | Dizziness | |
| 122415456 | 12241545 | Fall | |
| 122415456 | 12241545 | Headache | |
| 122415456 | 12241545 | Seizure | |
| 122415456 | 12241545 | Vomiting projectile |
Reporting Sources (this data is often not reported and may therefore be missing here)
| no results found |
Therapies reported
| Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
|---|---|---|---|---|---|---|
| 122415456 | 12241545 | 1 | 20160105 | 20160113 | 0 | |
| 122415456 | 12241545 | 2 | 20160105 | 0 | ||
| 122415456 | 12241545 | 3 | 20141016 | 0 | ||
| 122415456 | 12241545 | 4 | 20160109 | 20160113 | 0 | |
| 122415456 | 12241545 | 7 | 20160105 | 0 |